Nextgen Biomed Ltd (TASE:NXGN-M) announced that it will issue 2,616,147 shares without par value at a price of ILS 1.70 per share for gross proceeds of ILS 4,447,450 on December 8, 2020. The transaction will include participation from Abi Ben Tal for 281,500 shares and 281,500 warrants, Igor Korliandr for 118,000 shares and 118,000 warrants, Ofir Haim for 118,000 shares and 118,000 warrants, Uri Levin for 118,000 shares and 118,000 warrants, Asher Gabay for 600,000 shares and 600,000 warrants, Arie Weber for 180,000 shares and 180,000 warrants, Gal Shmaye for 588,236 shares and 588,236 warrants, Yona Attia for 294,117 shares and 294,117 warrants, Einav Cohen for 90,000 shares and 90,000 warrants and Moshe Birman for 235,294 shares and 235,294 warrants. The company will also issue 2,616,147 warrants, each exercisable into one share for a period of 6 months at a strike price of ILS 2.50. The transaction has been approved by board of directors of the company. The shares are subject to a hold period of 6 months. The company currently has issued and paid up share capital of 33,178,714 ordinary shares without par value.